Cancer in multiple sclerosis patients following prolonged exposure to disease-modifying therapies (DMTs): a systematic review and meta-analysis

被引：0
|
作者：
Vasileios Giannopapas [1 ]
Vassiliki Smyrni [2 ]
Dimitrios K. Kitsos [1 ]
Maria Ioanna Stefanou [1 ]
Aikaterini Theodorou [1 ]
John S. Tzartos [1 ]
Georgios Tsivgoulis [1 ]
Sotirios Giannopoulos [1 ]
机构：
[1] National & Kapodistrian University of Athens,Second Department of Neurology, Attikon University Hospital
[2] University of West Attica,Department of Physical Therapy
来源：
Journal of Neurology | 2025年 / 272卷 / 2期
关键词：
Multiple sclerosis; Autoimmune diseases; Cancer; Malignancy; Disease-modifying therapies;
D O I：
10.1007/s00415-024-12882-4
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Latent tuberculosis infection reactivation in patients with multiple sclerosis in use of disease-modifying therapies: A systematic review
    Dantas, Luiza Andraus
    Pereira, Marina Steingraber
    Gauza, Amanda de Miranda
    Bonetti Schulz, Maria Eduarda
    da Silva, Gustavo Figueiredo
    Marchi Martin, Maria Eduarda
    Gomes de Medeiros Junior, Washigton Luiz
    Magno Goncalves, Marcus Vinicius
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 55
  • [42] Cost-Effectiveness of Multiple Sclerosis Disease-Modifying Therapies: A Systematic Review of the Literature
    Yamamoto, David
    Campbell, Jonathan D.
    AUTOIMMUNE DISEASES, 2012, 2012
  • [43] Disease-modifying therapies used to treat multiple sclerosis and the gut microbiome: a systematic review
    Chia-Chen Tsai
    Sophia Jette
    Helen Tremlett
    Journal of Neurology, 2024, 271 : 1108 - 1123
  • [44] The Effect of Disease Modifying Therapies on Brain Atrophy in Patients with Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis
    Tsivgoulis, Georgios
    Katsanos, Aristeidis H.
    Grigoriadis, Nikolaos
    Hadjigeorgiou, Georgios M.
    Heliopoulos, Ioannis
    Kilidireas, Constantinos
    Voumvourakis, Konstantinos
    PLOS ONE, 2015, 10 (03):
  • [45] Disease-modifying therapies used to treat multiple sclerosis and the gut microbiome: a systematic review
    Tsai, Chia-Chen
    Jette, Sophia
    Tremlett, Helen
    JOURNAL OF NEUROLOGY, 2023, 271 (3) : 1108 - 1123
  • [46] The effect of disease-modifying therapies on brain atrophy in patients with clinically isolated syndrome: a systematic review and meta-analysis
    Tsivgoulis, Georgios
    Katsanos, Aristeidis H.
    Grigoriadis, Nikolaos
    Hadjigeorgiou, Georgios M.
    Heliopoulos, Ioannis
    Papathanasopoulos, Panagiotis
    Dardiotis, Efthimios
    Kilidireas, Constantinos
    Voumvourakis, Konstantinos
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2015, 8 (05) : 193 - 202
  • [47] Safety outcomes of disease-modifying therapies for relapsing-remitting multiple sclerosis: A network meta-analysis
    Lucchetta, Rosa C.
    Leonart, Leticia P.
    Becker, Jefferson
    Pontarolo, Roberto
    Fernandez-Llimos, Fernando
    Wiens, Astrid
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 35 : 7 - 15
  • [48] IMPACT OF A PHARMACY-LED MEDICATION ADHERENCE PROGRAM FOR DISEASE-MODIFYING THERAPIES (DMTS) IN PATIENTS WITH MULTIPLE SCLEROSIS (MS)
    Spina, Courtney
    Shull, Mariel
    Cherian, Sheena
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2018, 14 (05): : E10 - E10
  • [49] Infections in Patients Receiving Multiple Sclerosis Disease-Modifying Therapies
    Grebenciucova, Elena
    Pruitt, Amy
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2017, 17 (11)
  • [50] Persistence to oral disease-modifying therapies in multiple sclerosis patients
    Simona Lattanzi
    Maura Danni
    Ruja Taffi
    Raffaella Cerqua
    Giulia Carlini
    Alessandra Pulcini
    Leandro Provinciali
    Mauro Silvestrini
    Journal of Neurology, 2017, 264 : 2325 - 2329
12345